Patents by Inventor Csanky Eszter

Csanky Eszter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of detecting and treating pulmonary disease and markers thereof
    Patent number: 8501422
    Abstract: The present invention relates to the treatment of pulmonary diseases. More specifically, the invention relates to new methods of detecting and treating chronic obstructive pulmonary disease (COPD). In particular, the invention relates to a method of measuring one or more lipid metabolites in human body fluids as an indicator/biomarker of the progress of chronic obstructive pulmonary disease. The present invention also relates to a method of detecting and/or monitoring chronic obstructive pulmonary disease in a subject, the method comprising measuring the level of at least one lipid metabolite in a sample from the subject, wherein said level is indicative of COPD. The present invention also relates to a method of assessing the efficacy of a COPD treatment in a subject, the method comprising a step of measuring the level of at least one lipid metabolite in a sample from the subject, wherein said level is indicative of COPD severity or status.
    Type: Grant
    Filed: September 23, 2009
    Date of Patent: August 6, 2013
    Assignee: F. Hoffman-La Roche SA
    Inventors: Csanky Eszter, Ralph Ruhl, Laszlo Takacs, William Hempel
  • Methods of Detecting and Treating Pulmonary Disease and Markers Thereof
    Publication number: 20120021532
    Abstract: The present invention relates to the treatment of pulmonary diseases. More specifically, the invention relates to new methods of detecting and treating chronic obstructive pulmonary disease (COPD). In particular, the invention relates to a method of measuring one or more lipid metabolites in human body fluids as an indicator/biomarker of the progress of chronic obstructive pulmonary disease. The present invention also relates to a method of detecting and/or monitoring chronic obstructive pulmonary disease in a subject, the method comprising measuring the level of at least one lipid metabolite in a sample from the subject, wherein said level is indicative of COPD. The present invention also relates to a method of assessing the efficacy of a COPD treatment in a subject, the method comprising a step of measuring the level of at least one lipid metabolite in a sample from the subject, wherein said level is indicative of COPD severity or status.
    Type: Application
    Filed: September 23, 2009
    Publication date: January 26, 2012
    Applicant: Biosystems International SAS
    Inventors: Csanky Eszter, Ralph Ruhl, Laszlo Takacs, William Hempel